Healthcare -
Biotechnology - NASDAQ - US
$ 42.365
-1.29 %
$ 3.92 B
Market Cap
-6.74
P/E
RARE - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities RARE - Ultragenyx Pharmaceutical Inc.
-17.8 M
LAST VALUE
75.32%
2 YEAR CAGR
-6.38%
5 YEAR CAGR
17.62%
10 YEAR CAGR